XML 38 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Research and development expenses (Tables)
6 Months Ended
Jun. 30, 2024
Disclosure Of Detailed Information Research And Development Expenses [Abstract]  
Schedule of Breakdown of Research and Development Expenses

 

 

For the three months ended June 30,

 

For the six months ended June 30,

 

 

 

2024

 

2023

 

2024

 

2023

 

 

 

 

 

 

 

Clinical expenses

 

 

(15,065,644

)

 

(7,629,432

)

 

(22,387,056

)

 

(12,497,879

)

Personnel expenses (Note 5)

 

 

(6,450,500

)

 

(4,544,244

)

 

(11,630,976

)

 

(8,761,944

)

Manufacturing costs

 

 

(1,572,017

)

 

(736,427

)

 

(4,135,971

)

 

(2,643,513

)

Nonclinical expenses

 

 

130,020

 

 

(1,667,811

)

 

(1,705,446

)

 

(4,419,009

)

License costs

 

 

 

 

 

 

(1,500,000

)

 

 

Intellectual Property costs

 

 

(109,793

)

 

(104,021

)

 

(221,501

)

 

(104,021

)

 

 

 

(23,067,934

)

 

(14,681,935

)

 

(41,580,950

)

 

(28,426,366

)